Background: Decisions about how to treat patients with acute exacerbations of obstructive airways disease-chronic obstructive pulmonary disease (COPD), asthma or mixed diagnoses-often require an understanding of prognosis. This depends on the severity of the acute deterioration and the patient's functional reserve. There are currently no validated disease-specific scores that measure the severity of the acute exacerbation. Objective: To develop an acute physiology score for exacerbations of obstructive airways disease. Design: Secondary analysis of a high-quality clinical database, the Case Mix Programme Database. Setting: One hundred and sixty-eight adult, general critical care units in England, Wales and Northern Ireland. Results: A total of 8527 patients with obstructive airways disease were identified with a mean (SD) age of 65.9 (9.7) years and hospital mortality of 35.5%. The COPD and Asthma Physiology Score (CAPS) was developed using logistic regression. The CAPS included eight variables: heart rate, mean arterial blood pressure, pH, sodium, urea, creatinine, albumin and white blood cell count. The score had fair discrimination with an area under the receiver operating characteristic curve of 0.718. This performance was reproduced in a further validation dataset of 7957 patients. The discrimination of the CAPS in these validation data exceeded that of the acute physiology scores from APACHE II and III and the physiological components of SAPS II.
Introduction
Exacerbations of chronic obstructive pulmonary disease (COPD) are responsible for a substantial proportion of emergency medical admissions to hospital; by 2020, COPD is expected to become the third leading cause of death in the world. 1 The management of acute respiratory failure in COPD involves decisions about ventilatory support and an understanding of the patient's prognosis can be helpful in guiding such decisions. Clinicians can find such prognostication difficult 2 and prognostic models may have a role in supporting decision-making.
To date the US Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUP-PORT) has been the only adequately powered prospective study that has produced a predictive model for the prognosis of acutely ill COPD patients. It was better calibrated than clinicians in predicting mortality. 3 In common with outcome prediction models such as the Acute Physiology, Age and Chronic Health Evaluation (APACHE) III model, 4 the SUPPORT model contains a measure of function in the period of stability pre-exacerbation and a measure of the severity of the acute illness in terms of acute physiological measures. The weighting of risk factors in prognostic models requires at least 10 deaths per variable in order to avoid over fitting 5 and where variables are categorised into n levels, 10 deaths will be required for each of nÀ1 levels. For example, albumin categorised into three levels ofo29.9 g l -1 , 30-34.9 g l -1 and 4 35 g l -1 would require 20 deaths. Even with a sample size of 1016 patients SUPPORT did not have the power to develop a COPD specific acute physiology score and instead used the acute physiology score from APACHE III. However the SUPPORT workers found that giving additional weight to two factors already weighted in the acute physiology score from APACHE III-albumin and the PaO 2 / FiO 2 ratio-added additional explanatory power to the SUPPORT model, suggesting that disease-specific acute physiology scores are likely to be more useful than generic scores.
The transfer of prediction models between healthcare systems is problematic 6 and we therefore set out to produce a COPD outcome model to help physicians make decisions for COPD patients admitted to UK hospitals as emergencies (the COPD and Asthma Outcome Study or CAOS model). In the light of the lessons from SUPPORT we aimed to include in this model a disease specific acute physiology score developed using patients with obstructive airways disease admitted to UK intensive care units (ICUs). This paper describes the development of the COPD and Asthma Physiology Score (CAPS), which was designed to take account of the severity of the patient's current exacerbation for use alongside measures of the patient's functional reserve. In particular, it was intended for use prior to admission to critical care using physiological data that would be readily available and reliably measurable outside critical care areas.
As the explicit aim of the study was to use a large UK database to develop a model for acute physiology, no attempt was made to include variables that reflect functional reserve. Factors that reflect functional reserve, such as age and exercise tolerance, would be collected prospectively in the smaller CAOS study. The CAOS study and the development of the CAOS model is reported in detail elsewhere. 7 Briefly, it was a prospective observational cohort study that recruited patients over the age of 45 years admitted to intensive care with exacerbations of obstructive airways disease from 95 hospitals in England, Wales and Northern Ireland. Data were collected on patients' characteristics prior to ICU admission and used to develop an outcome model to predict 180-day mortality.
Methods

Case Mix Programme Database
Data were extracted for 276,731 admissions to 168 adult, general critical care units-ICUs and combined intensive care/high dependency units-participating in the Case Mix Programme, the national comparative audit of critical care in England, Wales and Northern Ireland. The data underwent extensive validation, both locally and centrally, before inclusion in the Case Mix Programme Database. Further details of the data collection and validation process have been published previously. 8 The 
Selection of cases
Primary and secondary reasons for admission to the critical care unit are recorded in the Case Mix Programme using a specially derived hierarchical approach, the ICNARC Coding Method. 9 Cases were extracted from the Case Mix Programme Database if they were at least 45 years old on admission to the critical care unit and met either of the following two conditions: The diagnostic codes included all those that clinicians would use for patients considered to have exacerbations of obstructive airways disease. In older smokers in the acute setting it can be difficult to distinguish between patients with pure asthma from those with chronic obstructive airways disease and it was for this reason that patients given the label asthma were also included. This allows the acute physiology score to be used in a fuller model that includes a variable for the most likely diagnosis of the airflow obstruction choosing between pure COPD, pure asthma or a mixture of COPD and asthma.
Cases were excluded if: (1) they were admitted directly from theatre or from theatre via any other location in the same hospital, or had a condition requiring surgery specified as either the primary or secondary reason for admission; (2) they were readmissions of the same patient within the same hospital stay; or (3) they were missing the primary outcome variable of mortality at ultimate discharge from an acute hospital.
These inclusion and exclusion criteria were chosen to match as closely as possible the patient group included in CAOS. Also admissions to units participating in CAOS during the time period of the study were excluded, as the final score was to be used in the analysis of CAOS and we wished the development dataset to remain independent.
Selection of physiological variables
Variables were selected, a priori, for inclusion in the full model if they were available in the Case Mix Programme Database, and had been shown to have a relationship with mortality in patients with COPD or asthma in the literature or in previous analyses of the Case Mix Programme Database 10, 11 and could be reliably collected outside ICU. Qualitative data from the CAOS study were used to identify variables that were readily available and reliably measured outside ICU. CAOS study data identified that though the ratio of PaO 2 to FiO 2 had shown a significant relationship with outcome in patients with COPD inside ICU, 10 in the pre-ICU setting the FiO 2 was frequently unavailable and so it was dropped.
The following variables were selected, measured over the first 24 h following admission to ICU: lowest central temperature (or lowest non-central temperature +1 1C if no central temperatures recorded); mean arterial pressure from the blood pressure with the lowest systolic pressure; extreme heart rate (furthest from 75 min -1 ); lowest arterial pH; PaCO 2 from the arterial blood gas with the lowest pH; lowest serum sodium; extreme serum potassium (furthest from 4.5 mmol l -1 ); highest serum urea; highest serum creatinine; highest serum glucose; highest total serum bilirubin; lowest serum albumin; and lowest white blood cell count.
Statistical methods
The relationship between each continuous physiological variable and outcome was examined graphically by fitting a flexible smooth function (generalised additive model with five degrees of freedom) to the log odds of hospital mortality. 12 These plots were used to divide the continuous variables into a number of categories. Each categorical variable was then entered into a logistic regression model and adjacent categories were combined if they were not significantly different at the 10% level. Missing physiological values were assumed to be in the normal range (defined as the category with the lowest mortality). Imputation methods were not considered appropriate as the assumption that data were missing at random was highly likely to be violated. As a sensitivity analysis, the model development was repeated assigning missing values to the category with the highest mortality.
All 13 categorical variables were entered into the full model. The modelling proceeded in a stepwise manner, with the least significant variable being removed at each step, until no variables remained. At each step, the model was fitted in a randomly selected development sample of two thirds of all ICUs and evaluated in a validation sample of the remaining one third of ICUs. The random split into development and validation samples was repeated 100 times to avoid biasing the results by a single random split of the data, the model was refitted in each of the 100 development samples and measures of discrimination and calibration were reported as the median and quartiles over the 100 validation samples. Discrimination was assessed with the area under the receiver operating characteristic (ROC) curve, 13 and calibration with the Hosmer-Lemeshow C statistic. 14 During the course of the development work, many more patients were admitted to units participating in the Case Mix Programme. This provided the opportunity to validate the discrimination of the CAPS in an independent validation sample. The discrimination of the CAPS was compared to that of the APACHE II acute physiology score, 15 APACHE III acute physiology score, 4 and the physiological components of SAPS II 16 in these validation data. Validation was carried out in all new admissions meeting the inclusion criteria for this study, and also, for a truly independent sample, restricted only to admissions to ICUs that had recently joined the Case Mix Programme and had no data in the development sample. Admissions were classified as COPD, asthma or mixed diagnoses based on the primary and secondary reasons for admission as recorded in the database and the discrimination of the CAPS was compared between these three groups.
All analyses were performed in Stata version 8.2 (StataCorp LP, College Station, TX, USA). Logistic regression models were fitted with robust standard errors, clustered by ICU. By the end of the development work, data had been received and validated on an additional 217,345 ICU admissions. Of these, 7957 (3.7%) met the inclusion criteria for this study, including 391 admissions to 13 new units that had no data in the development dataset. The characteristics of these patients are also described in Table 1 . Table 2 shows the stepwise selection of variables for the CAPS. The full model had a median area under the ROC curve of 0.720 and a median Hosmer-Lemeshow C statistic of 15.5 in the 100 validation samples. Dropping the least significant variables in turn initially had no effect on the discrimination (area under the ROC curve) and improved the calibration (Hosmer-Lemeshow C statistic) in the validation samples, suggesting that these variables made no contribution to the fit of the model. The model with eight variables was selected for the CAPS (indicated by bold type in Table  2 ). The eight variables were (in decreasing order of significance): serum urea, mean arterial blood pressure, serum albumin, serum creatinine, white blood cell count, arterial pH, serum sodium, and heart rate. This model had a median area under the ROC curve of 0.718 and a median Hosmer-Lemeshow C statistic of 13.4 in the 100 validation samples, representing a slight improvement in calibration with very little loss in discrimination compared to the full model. This compares favourably to the area under the ROC curves for the acute physiology scores from APACHE II, APACHE III and the physiological components of SAPS II (Table 1) . Calibration was not perfect, with 23% of validation samples showing significant departures from perfect Table 2 Stepwise selection of physiological variables models fitted in 100 random development samples (one third of units) and evaluated in the corresponding validation samples (remaining two thirds of units).
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Development of the COPD and Asthma Physiology Score
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Variables dropped
Number of variables calibration at the 5% significance level. This is to be expected, firstly because many known prognostic factors for COPD were not included in the model as we were only evaluating physiological derangement, and secondly because such a large sample size has the power to detect even very small variations from perfect calibration as being significant. Table 3 shows the eight physiological variables that were retained in the final score and the points ascribed to the ranges of values of these variables that go to make up the CAPS. In general, it can be seen that the further a physiological parameter strays from normal the greater the score it attracts, indicating a higher risk of mortality. The score ranges from zero to a maximum score of 100. Figure 1 shows the distribution of the CAPS amongst the 8527 admissions in the development dataset. The median (interquartile range) score was 34 (27-43), with 8.1% of admissions having a score below 20, 58.9% between 20 and 39, 29.1% between 40 and 59, and only 3.9% with a score of 60 or more. Figure 2 shows the relationship between the CAPS and mortality in the development dataset, and Table 4 shows the odds ratios for hospital mortality for each component of the CAPS both unadjusted and adjusted for all other CAPS components.
Physiological values were missing for between 1% and 2% (routine measurements: heart rate, mean arterial blood pressure, temperature), 4-6% (common additional tests: arterial blood gases, sodium, potassium, creatinine, white blood cell count) and 14-32% (less common tests: urea, glucose, albumin, bilirubin). The sensitivity analysis, allocating missing values to the category with the highest mortality, resulted in no change in the eight variables selected for the model and little difference to the overall fit of the model; however, the weightings produced by this model were inappropriate as high risk categories (containing missing values) were allocated low weights.
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Validation of the COPD and Asthma Physiology Score
The area under the ROC curve for the CAPS was 0.720 (95% confidence interval 0.708-0.732) in the independent validation data. This was significantly higher than for the APACHE II Figure 3 shows a comparison of the ROC curves for admissions with COPD (n ¼ 6646), asthma (n ¼ 1121) and mixed diagnoses (n ¼ 100) in the independent validation data. Discrimination of the CAPS was better for admissions with asthma than COPD (P ¼ 0.036), the sample with mixed diagnoses being too small to make any meaningful comparisons.
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Discussion
This study has developed a disease-specific acute physiology score for use in patients with acute exacerbations of obstructive airways disease. The study is a response to the problem that risk adjustment models taking account of acute physiology will typically require very large numbers of patients, and to date there have been no prospective studies of COPD patients with acute exacerbations that have had adequate power to weight the prognostic significance of acute physiological variables.
The CAPS uses eight physiological variables classified into 41 levels with a minimum of 340 deaths required to have the power to weight the score without a material risk of overfitting. 5 ICUs possess the infrastructure to collect case mix data on admissions and allowed this study to use data from 8527 admissions and 3025 deaths to establish the weights that should be given to the physiological variables. Collecting data outside ICU is far more difficult and even the $26 million SUPPORT study which is the largest prospective study to develop a prognostic model for hospitalized COPD patients only recruited 1016 COPD patients with 250 deaths by 180 days. 3 Despite the CAOS study recruiting from 95 hospitals for 18 months, only 651 patients without treatment limitation were identified prior to ICU admission with 220 deaths by 180 days.
The strengths of the CAPS are that the variables used were identified from the literature as having a potential to predict COPD survival and were also found in the CAOS study to be practical to collect in the acute setting. In addition, the CAPS has the theoretical advantage over generic scores such as APACHE III, which are developed using all diagnostic groups, of being disease-specific: specifically developed on patients admitted to ICU with exacerbations of obstructive airways disease.
The discrimination of the CAPS for predicting hospital mortality significantly exceeded that of the acute physiology scores from APACHE II and APACHE III and the physiological components of SAPS II in the validation data, despite being a simpler model, based on observations of only eight physiological parameters compared with 12, 16 and 12 parameters for APACHE II, APACHE III and SAPS II, respectively.
The use of outcome models to support decision-making is seen by some commentators to be problematic in that such models will produce outcome predictions that describe the average outcomes for similar patients but the ultimate outcome for the individual patient remains unknown. It should be remembered that such scores also have utility in case mix adjustment and audit studies that look at cohort outcomes. When it comes to individual patients, if prognostication is to have any role in decisionmaking then a prognostic estimate will need to come from somewhere. In the SUPPORT study, when clinicians' outcome predictions for COPD patients were compared to the SUPPORT model clinicians' predictions had a lower ROC, were less well calibrated and were pessimistic. 3 It could be argued that if clinicians' estimates are poorly calibrated then using a score alongside clinical judgement may well improve prognostic estimates, and the SUPPORT study confirmed this. It might also be argued that in the face of uncertainty all patients should be admitted, but simulation studies in the UK suggest that patients are refused intensive care on the basis of prognosis and that when clinicians make judgements about identical patients disagreements occur with non-admitters forming markedly more pessimistic prognoses. 2 In the light of this, we would consider objective prognostic estimates, with acknowledged uncertainty, to be a useful adjunct to clinical judgement.
In conclusion, the CAPS can be used to estimate the prognostic impact of the physiological derangements accompanying an acute exacerbation of obstructive airways disease and has the potential for even greater predictive performance when used in combination with measures of a patient's functional reserve. Further validation of this score outside of ICU and outside of the UK setting is recommended. Figure 3 Receiver operating characteristic curves for the COPD and Asthma Physiology Score in admissions with COPD, asthma and mixed diagnoses in the independent validation data.
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